Effect of EphB4 on primary human CD34+ cells cultured with SCF, TPO, and FL
. | CD41 . | GlycophrinA . | CD14 . | CD33 . | ||||
---|---|---|---|---|---|---|---|---|
Vector . | EphB4 . | Vector . | EphB4 . | Vector . | EphB4 . | Vector . | EphB4 . | |
Sample no. | ||||||||
1 | 4.1 | 13.8 | 3.8 | 11.1 | — | — | — | — |
2 | 2.9 | 8.4 | 2.0 | 10.5 | 27.2 | 40.3 | 65.4 | 67.4 |
3 | 6.8 | 15.2 | 2.8 | 4.6 | 41.0 | 33.9 | 97.4 | 97.8 |
4 | 30.2 | 59.8 | 18.8 | 31.7 | 54.5 | 44.7 | 97.2 | 98.9 |
5 | 24.4 | 35.4 | 10.2 | 25.2 | 43.5 | 44.6 | 89.5 | 98.1 |
Mean | 13.7 | 26.5 | 7.5 | 16.6 | 41.6 | 40.9 | 87.4 | 90.6 |
P | .020 | .008 | .131 | .092 |
. | CD41 . | GlycophrinA . | CD14 . | CD33 . | ||||
---|---|---|---|---|---|---|---|---|
Vector . | EphB4 . | Vector . | EphB4 . | Vector . | EphB4 . | Vector . | EphB4 . | |
Sample no. | ||||||||
1 | 4.1 | 13.8 | 3.8 | 11.1 | — | — | — | — |
2 | 2.9 | 8.4 | 2.0 | 10.5 | 27.2 | 40.3 | 65.4 | 67.4 |
3 | 6.8 | 15.2 | 2.8 | 4.6 | 41.0 | 33.9 | 97.4 | 97.8 |
4 | 30.2 | 59.8 | 18.8 | 31.7 | 54.5 | 44.7 | 97.2 | 98.9 |
5 | 24.4 | 35.4 | 10.2 | 25.2 | 43.5 | 44.6 | 89.5 | 98.1 |
Mean | 13.7 | 26.5 | 7.5 | 16.6 | 41.6 | 40.9 | 87.4 | 90.6 |
P | .020 | .008 | .131 | .092 |
CD34+ cells were transduced with MSCV-GFP (vector) or MSCV-EphB4 (EphB4). GFP+ cells were sorted and cultured in the presence of SCF (50 ng/mL), TPO (25 ng/mL), and flt3 ligand (FL) (50 ng/mL) for 7 days. P values were calculated using Wilcoxon matched-pairs signed-rank test.